School of Public Health: Chemtob Daniel

1.

Rouvinski A, Friedman A, Kirillov S, Attal JH, Kumari S, Fahoum J, et al. Antibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine. Scientific Reports [Internet]. 2023;13(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85169009864&doi=10.1038%252fs41598-023-41399-5&partnerID=40&md5=01ba2be88fc27034f5cab0089b1b9809

2.

Günther G, Guglielmetti L, Leu C, van Leth F, Lange C, Hafizi H, et al. Relative cost of multidrug-resistant TB medicines in Europe. International Journal of Tuberculosis and Lung Disease [Internet]. 2023;27(5):341–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159549068&doi=10.5588%252fijtld.23.0026&partnerID=40&md5=581c94d3a46300a291d5a6debdc53556

3.

Wiessing L, Sypsa V, Abagiu AO, Arble A, Berndt N, Bosch A, et al. Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel. AIDS and Behavior [Internet]. 2023;27(4):1140–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141787278&doi=10.1007%252fs10461-022-03851-x&partnerID=40&md5=e4830e0234f6683d048eadba72b19bd6

4.

Günther G, Guglielmetti L, Leu C, Lange C, van Leth F, Hafizi H, et al. Availability and costs of medicines for the treatment of tuberculosis in Europe. Clinical Microbiology and Infection [Internet]. 2023;29(1):77–84. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138577531&doi=10.1016%252fj.cmi.2022.07.026&partnerID=40&md5=ff95f4a00562712b83987f27afaf413b

5.

Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia-Basteiro AL, et al. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal [Internet]. 2022;59(5). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130397640&doi=10.1183%252f13993003.00388-2022&partnerID=40&md5=37a14a38becb4c8ee4a3205e412f6982

6.

Wagner T, Zuckerman NS, Halperin T, Chemtob D, Levy I, Elbirt D, et al. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018. Viruses [Internet]. 2022;14(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122154121&doi=10.3390%252fv14010071&partnerID=40&md5=1bc717e39b853804d15a723bd305a227

7.

Chemtob D, Levy I, Kaufman S, Averick N, Krauss A, Turner D. Drop-out of medical follow-up among people living with HIV in Tel-Aviv area. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV [Internet]. 2022;34(5):621–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100976310&doi=10.1080%252f09540121.2021.1883516&partnerID=40&md5=74c5317b4d8d2826e11b15b4dd564a22

8.

Chemtob D, Weil C, Attal JH, Hawila E, Sadeh EN. HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis. PLoS ONE [Internet]. 2021;16(11 November). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119526465&doi=10.1371%252fjournal.pone.0259168&partnerID=40&md5=2b9bcb9c3c56f62d3ea91211d83cb4dc

9.

Chemtob D, Ogum E. Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries. Israel Journal of Health Policy Research [Internet]. 2020;9(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088907600&doi=10.1186%252fs13584-020-00386-1&partnerID=40&md5=0de62721f51b44037fc286aa7c77676a

10.

Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, et al. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. The Lancet HIV [Internet]. 2020;7(6):e434–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085761355&doi=10.1016%2fS2352-3018%2820%2930082-5&partnerID=40&md5=79e0ab2eac621dc8a39d10636d2ca03c

11.

Chowers M, Chemtob D, Mor O, Levy I, Elbirt D, Elinav H, et al. Continuum of HIV care of newly diagnosed individuals in Israel, 2011–2015: a population-based cohort study. International Journal of STD and AIDS [Internet]. 2020;31(4):326–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081063262&doi=10.1177%252f0956462419891023&partnerID=40&md5=cee900d507d323b1ef2c922df1032af0

12.

Ginsberg GM, Chemtob D. Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel. BMC Public Health [Internet]. 2020;20(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080098626&doi=10.1186%252fs12889-020-8334-4&partnerID=40&md5=c36fa27cdf604d712d2cac7b12c996ee

13.

Bishara H, Green M, Chemtob D, Saffouri A, Zelikman L, Weiler-Ravell D. Ongoing tuberculosis transmission among second-generation Ethiopian immigrants in Israel. Epidemiology and Infection [Internet]. 2020; Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090077601&doi=10.1017%252fS0950268820001715&partnerID=40&md5=80013715ff769cdc173e009afac0aa89

14.

Mårdh O, Quinten C, Kuchukhidze G, Seguy N, Dara M, Amato-Gauci AJ, et al. HIV among women in the WHO European Region – Epidemiological trends and predictors of late diagnosis, 2009-2018. Eurosurveillance [Internet]. 2019;24(48). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075945600&doi=10.2807%252f1560-7917.ES.2019.24.48.1900696&partnerID=40&md5=85e333610105ca40142addb28a5ad7b6

15.

Hayes R, Schmidt AJ, Pharris A, Azad Y, Brown AE, Weatherburn P, et al. Estimating the “PrEP Gap”: How implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Eurosurveillance [Internet]. 2019;24(41). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073474764&doi=10.2807%252f1560-7917.ES.2019.24.41.1900598&partnerID=40&md5=67dafc22b1aea96903daee115866fabe

16.

Chemtob D, Mor Z, Harel N, Averick N. HIV infection among men who have sex with men in Israel: A 35-year epidemiological and clinical overview, 1981-2015. BMC Public Health [Internet]. 2019;19(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067307337&doi=10.1186%252fs12889-019-7000-1&partnerID=40&md5=bcbe9ec538f60eff05e24075ff23f692

17.

Ganzel C, Silverman B, Chemtob D, Ben Shoham A, Wiener-Well Y. The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study. Leukemia and Lymphoma [Internet]. 2019;60(3):720–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053341702&doi=10.1080%252f10428194.2018.1499904&partnerID=40&md5=b57db0e3b341cc0af1edbd4e2e18698c

18.

Kiros YK, Elinav H, Gebreyesus A, Gebremeskel H, Azar J, Chemtob D, et al. Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel. HIV Medicine [Internet]. 2019;20(1):33–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054900480&doi=10.1111%252fhiv.12680&partnerID=40&md5=841d5436babad75598da1e4d827bae82

19.

Brown AE, Hayes R, Noori T, Azad Y, Amato-Gauci AJ, Pharris A, et al. HIV in Europe and central Asia: Progress in 2018 towards meeting the UNAIDS 90-90-90 targets. Eurosurveillance [Internet]. 2018;23(48). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059795338&doi=10.2807%252f1560-7917.ES.2018.23.48.1800622&partnerID=40&md5=02b02eb25297e18e69f2100851e34b4f

20.

Bui LV, Mor Z, Chemtob D, Ha ST, Levine H. Use of geographically weighted poisson regression to examine the effect of distance on tuberculosis incidence: A case study in Nam Dinh, Vietnam. PLoS ONE [Internet]. 2018;13(11). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056301101&doi=10.1371%252fjournal.pone.0207068&partnerID=40&md5=4d96ad376a83c2a61b582b9a37dc8ad6

21.

Avidor B, Chemtob D, Turner D, Zeldis I, Girshengorn S, Matus N, et al. Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays – A step towards an improved national algorithm. Journal of Clinical Virology [Internet]. 2018;106:18–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049738509&doi=10.1016%252fj.jcv.2018.06.017&partnerID=40&md5=6adc53321b66782d10bd261fdc8277de

22.

Popovici O, Monk P, Chemtob D, Chiotan D, Freidlin PJ, Groenheit R, et al. Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania. Epidemiology and Infection [Internet]. 2018;146(7):824–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047186709&doi=10.1017%252fS095026881800047X&partnerID=40&md5=3dc44c640a69fc8f6863175a957df7b5

23.

Rakovsky A, Gozlan Y, Bassal R, Wax M, Shirazi R, Bakhanashvili M, et al. Diagnosis of HIV-1 infection: Performance of Xpert Qual and Geenius supplemental assays in fourth generation ELISA-reactive samples. Journal of Clinical Virology [Internet]. 2018;101:7–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041385110&doi=10.1016%252fj.jcv.2018.01.007&partnerID=40&md5=daa11124fe134c8c803ed27365704c50

24.

Mor Z, Sheffer R, Chemtob D. Causes of death and mortality trends of all individuals reported with HIV/AIDS in Israel, 1985-2010. Journal of Public Health (United Kingdom) [Internet]. 2018;40(1):56–64. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044372917&doi=10.1093%252fpubmed%252ffdx039&partnerID=40&md5=33b58b6e6eacece4871d004bf12476d7

25.

Mor Z, Sheffer R, Chemtob D. Mother-to-child HIV transmissions in Israel, 1985-2011. Epidemiology and Infection [Internet]. 2017;145(9):1913–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017166449&doi=10.1017%252fS0950268817000577&partnerID=40&md5=b1fd5834ca9f664968d80a587e4f9bda

26.

Katchman E, Ben-Ami R, Savyon M, Chemtob D, Avidor B, Wasserman A, et al. Successful control of a large outbreak of HIV infection associated with injection of cathinone derivatives in Tel Aviv, Israel. Clinical Microbiology and Infection [Internet]. 2017;23(5):336.e5-336.e8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011591417&doi=10.1016%252fj.cmi.2016.11.009&partnerID=40&md5=c067f8f0d49f721dd818226cd216b872

27.

Chemtob D, Gandacu D, Mor Z, Grotto I, Anis E, Rosenberg E. A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025. Israel Journal of Health Policy Research [Internet]. 2017;6(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018487913&doi=10.1186%252fs13584-017-0141-8&partnerID=40&md5=b094dd9ffd48e377f5d798be62a131ae

28.

Freidlin PJ, Nissan I, Luria A, Goldblatt D, Schaffer L, Kaidar-Shwartz H, et al. Structure and variation of CRISPR and CRISPR-flanking regions in deleted-direct repeat region Mycobacterium tuberculosis complex strains. BMC Genomics [Internet]. 2017;18(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013213166&doi=10.1186%252fs12864-017-3560-6&partnerID=40&md5=77dfbc49200d7b27ee1f1901d8fdab48

29.

Chowers M, Regev-Yochay G, Mor O, Cohen-Poradosu R, Riesenberg K, Zimhony O, et al. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009–2014. Human Vaccines and Immunotherapeutics [Internet]. 2017;13(1):216–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010762644&doi=10.1080%252f21645515.2016.1229720&partnerID=40&md5=3efdeea98be0a4db54255be22d22f612

30.

Ginsberg GM, Shinar E, Kopel E, Chemtob D. Should Men who have sex with Men be allowed to donate blood in Israel. Israel Journal of Health Policy Research [Internet]. 2016;5(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85004091909&doi=10.1186%252fs13584-016-0123-2&partnerID=40&md5=575221573af89ff9ab66dd872583b452

31.

Mor Z, Lidji M, Chemtob D, Cedar N, Grotto I. Erratum: “HIV prevalence in the Israeli tuberculosis cohort, 1999-2011” (BMC Public Health (2014) 14 (1090)). BMC Public Health [Internet]. 2016;16(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963812210&doi=10.1186%252fs12889-016-2889-0&partnerID=40&md5=a6da05be6362762bd941aa7f287a79ae

32.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. Clinical Infectious Diseases [Internet]. 2016;62(5):655–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960114637&doi=10.1093%252fcid%252fciv963&partnerID=40&md5=e74c77fe8d4855063873fc052c45f75d

33.

Shuldiner J, Leventhal A, Chemtob D, Mor Z. Mortality after anti-tuberculosis treatment completion: Results of long-term follow-up. International Journal of Tuberculosis and Lung Disease [Internet]. 2016;20(1):43–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84951910294&doi=10.5588%252fijtld.14.0427&partnerID=40&md5=2814f38ada45f3599a4e65534a0a424c

34.

Chemtob D, Op de Coul E, van Sighem A, Mor Z, Cazein F, Semaille C. Impact of Male Circumcision among heterosexual HIV cases: Comparisons between three low HIV prevalence countries. Israel Journal of Health Policy Research [Internet]. 2015;4(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938718116&doi=10.1186%252fs13584-015-0033-8&partnerID=40&md5=afda178b31a04bfe83ddd44ed2514103

35.

Chemtob D, Mor Z, Grotto I. Tuberculosis screening programmes for migrants to low-incidence countries-the Israeli experience. The Lancet Infectious Diseases [Internet]. 2015;15(8):876. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937709568&doi=10.1016%2fS1473-3099%2815%2900138-3&partnerID=40&md5=461483cee381075b7fb5389609886dd6

36.

Lönnroth K, Migliori GB, Abubakar I, D’Ambrosio L, De Vries G, Diel R, et al. Towards tuberculosis elimination: An action framework for low-incidence countries. European Respiratory Journal [Internet]. 2015;45(4):928–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922970030&doi=10.1183%252f09031936.00214014&partnerID=40&md5=f5eb75ae2b8409e20f4a609ab11613f1

37.

Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D. Drug-resistant tuberculosis in Israel: Risk factors and treatment outcomes. International Journal of Tuberculosis and Lung Disease [Internet]. 2014;18(10):1195–201. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907175711&doi=10.5588%252fijtld.14.0192&partnerID=40&md5=667482a388193036032e8b259db9de06

38.

Goldblatt D, Rorman E, Chemtob D, Freidlin PJ, Cedar N, Kaidar-Shwartz H, et al. Molecular epidemiology and mapping of tuberculosis in Israel: Do migrants transmit the disease to locals? International Journal of Tuberculosis and Lung Disease [Internet]. 2014;18(9):1085–91. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906705258&doi=10.5588%252fijtld.14.0186&partnerID=40&md5=8fd39cdfe52154e3992ec265897c05f1

39.

Frentz D, Van de Vijver DAMC, Abecasis AB, Albert J, Hamouda O, Jørgensen LB, et al. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infectious Diseases [Internet]. 2014;14(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904448066&doi=10.1186%252f1471-2334-14-407&partnerID=40&md5=180cf1d069e96d49f9b9d3cfc0e40c04

40.

Shuldiner J, Leventhal A, Chemtob D, Mor Z. Mortality of tuberculosis patients during treatment in israel, 2000-2010. International Journal of Tuberculosis and Lung Disease [Internet]. 2014;18(7):818-823+ii. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903485029&doi=10.5588%252fijtld.13.0591&partnerID=40&md5=09f5f67625dfe33d3c271063cfaa530a

41.

D’Ambrosio L, Dara M, Tadolini M, Centis R, Sotgiu G, Van Der Werf MJ, et al. Tuberculosis elimination: Theory and practice in Europe. European Respiratory Journal [Internet]. 2014;43(5):1410–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896477367&doi=10.1183%252f09031936.00198813&partnerID=40&md5=2096fec85ce9fedc58c255654ddee047

42.

Mor Z, Weinstein R, Grotto I, Levin Y, Chemtob D. Thirty years of HIV in Israel: Current epidemiology and future challenges. BMJ Open [Internet]. 2013;3(7). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880580224&doi=10.1136%252fbmjopen-2013-003078&partnerID=40&md5=5fcbaf6b4effb7e00176236abe318653

43.

Frentz D, Wensing AMJ, Albert J, Paraskevis D, Abecasis AB, Hamouda O, et al. Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology [Internet]. 2013;10(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875650684&doi=10.1186%252f1742-4690-10-36&partnerID=40&md5=e30f4d3a924ccfb1401054d6c737a09d

44.

Theys K, Deforche K, Vercauteren J, Libin P, van de Vijver DAMC, Albert J, et al. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology [Internet]. 2012;9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866850986&doi=10.1186%252f1742-4690-9-81&partnerID=40&md5=d2f3b2e40111e9f8081888341d0aa3ec

45.

Chemtob D, Zenilman JM, Gandacu D. What do we need to learn for policy decision-making on sexually transmitted infections prevention and treatment in Israel? International Journal of STD and AIDS [Internet]. 2012;23(9):e11–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867090901&doi=10.1258%252fijsa.2009.009338&partnerID=40&md5=815f9b72a7dd14163392e7a8463f06f1

46.

Merrick J, Talnir R, Gross S, Chemtob D, Aspler S, Kandel I, et al. Human immunodeficiency virus (HIV) and persons with disability/intellectual disability [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060182021&partnerID=40&md5=c71edea71ec95351a6d00dfe673e75c2

47.

Schenker I, Chemtob D, Yamin N, Shtechman N, Rosenberg H. The National HIV/AIDS hotline in Israel: Data on utilization, quality assurance and content [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060174571&partnerID=40&md5=0dad7072a6753ceedb09497c4d76e5a9

48.

Chemtob D, Gurevitz M, Levitt S, Basudo-Manor N, Shufman E, Maayan S. Epidemiology of Hepatitis B, Hepatitis C and HIV infections among intravenous drug users in Jerusalem, Israel [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060154707&partnerID=40&md5=a8e8192369ef8b3168afdf9d96350ac2

49.

Chemtob D, Merrick J. Introduction: Preventing and treating tuberculosis and HIV/AIDS. A worldwide public health challenge [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060152376&partnerID=40&md5=3e6d39070cdd8154cadb6f0149f8832d

50.

Chemtob D, Merrick J. AIDS and Tuberculosis: Public Health Aspects [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060148508&partnerID=40&md5=43ec76b88ce97f14ec1ec1a7ccedf6fc

51.

Chemtob D, Rosenberg E. Healthy Israel 2020: Objectives, targets, and evidence-based strategies to prevent tuberculosis and HIV infection in Israel [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060139561&partnerID=40&md5=4142e2570c4242254c3978f806066180

52.

Gross S, Merrick J, Talnir R, Aspler S, Kandel I, Morad M, et al. Human immunodificiency virus (HIV) in a residential care center for persons with intellectual disability in Israel: A needle in a haystack investigation [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060136692&partnerID=40&md5=828be5d466dc2b9485c355da3f0d0d46

53.

Mor Z, Davidovich U, Bessudu-Manor N, McFarlane M, Feldshtein G, Chemtob D. High-risk behaviour in steady and in casual relationships among men who have sex with men in Israel. Sexually Transmitted Infections [Internet]. 2011;87(6):532–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052917753&doi=10.1136%252fsextrans-2011-050048&partnerID=40&md5=1ad41ffdbea35a97a3a03f4ac2681a48

54.

Alvarez GG, Clark M, Altpeter E, Douglas P, Jones J, Paty MC, et al. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries (International Journal of Tuberculosis and Lung Disease (2010) 14, 12, (1530-1537)). International Journal of Tuberculosis and Lung Disease [Internet]. 2011;15(3):425. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951636236&partnerID=40&md5=254211eaea21c8f1fa7d66a7e998dac1

55.

Alvarez GG, Gushulak B, Rumman KA, Altpeter E, Chemtob D, Douglas P, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infectious Diseases [Internet]. 2011;11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650775252&doi=10.1186%252f1471-2334-11-3&partnerID=40&md5=b75299a4c3af0f52e80e6e3002bc6873

56.

Alvarez GG, Clark M, Altpeter E, Douglas P, Jones J, Paty MC, et al. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries. International Journal of Tuberculosis and Lung Disease [Internet]. 2010;14(12):1530–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649372679&partnerID=40&md5=17ca1dac3c026c59d5be2c941444e4c9

57.

Erkens CGM, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, et al. Tuberculosis contact investigation in low prevalence countries: A European consensus. European Respiratory Journal [Internet]. 2010;36(4):925–49. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956599594&doi=10.1183%252f09031936.00201609&partnerID=40&md5=17b5ea0ebc23417994b2fe2f9abd4130

58.

Chemtob D, Levy A. Rationale and staff evaluation of using a therapeutic milieu for substance users within a tuberculosis ward. Substance Use and Misuse [Internet]. 2009;44(5):672–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649236067&doi=10.1080%252f10826080802494701&partnerID=40&md5=cdc68631a3d8a9ca97f56b5b7d1fa972

59.

Attamna A, Chemtob D, Attamna S, Fraser A, Rorman E, Paul M, et al. Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: A nationwide cohort. Thorax [Internet]. 2009;64(3):271. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-61649117959&doi=10.1136%252fthx.2008.100974&partnerID=40&md5=bf28172529832d001daa816aef95684b

60.

Bothamley GH, Ditiu L, Migliori GB, Lange C, Hafizi H, Mezhlumyan N, et al. Active case finding of tuberculosis in Europe: A Tuberculosis Network European Trials Group (TBNET) survey. European Respiratory Journal [Internet]. 2008;32(4):1023–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-58149251629&doi=10.1183%252f09031936.00011708&partnerID=40&md5=1e6a18d6bf32bc84bcf7df855f018531

61.

Mor Z, Davidovich U, McFarlane M, Feldshtein G, Chemtob D. Gay men who engage in substance use and sexual risk behaviour: A dual-risk group with unique characteristics. International Journal of STD and AIDS [Internet]. 2008;19(10):698–703. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-53549090445&doi=10.1258%252fijsa.2008.008061&partnerID=40&md5=a954b02b45d883ac8c010bf3e52f0a8e

62.

Chemtob D, Levit S, Mell H, Margolis A, Levy A, Leventhal A. “Injecting clean or being clean?” The International and Israeli experiences of Syringe Exchange Programs among injecting drugs users. Harefuah [Internet]. 2008;147(7):634–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-53849133118&partnerID=40&md5=f1f58de5b02395e45f8f8f11e1ab97af

63.

Chemtob D. Mortality of hospitalized tuberculosis patients in Israel. The Israel Medical Association journal : IMAJ [Internet]. 2008;10(3). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-44849083815&partnerID=40&md5=861c70a3b1b5c5080a04f2ecc032b750

64.

Mor Z, Adler A, Leventhal A, Volovic I, Rosenfeld E, Lobato MN, et al. Tuberculosis behind bars in Israel: Policy making within a dynamic situation. Israel Medical Association Journal [Internet]. 2008;10(3):202–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43249123225&partnerID=40&md5=33cbf73b3e34d2418e470c039b6f4c63

65.

Mor Z, Chemtob D, Hildesheimer GM, Leventhal A. Aids and the right to privacy. Harefuah [Internet]. 2007;146(3):200–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547420552&partnerID=40&md5=adb6e53a6aecc92f19ceedb41501998f

66.

Chemtob D, Sasson M, Leventhal A, Stein-Zamir C, Maayan S. Sexually transmitted infections among individuals with and without HIV [1]. Israel Medical Association Journal [Internet]. 2006;8(12):892. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845885771&partnerID=40&md5=02c58beeaea75a9d5d94aa9270f47d27

67.

Mor Z, Chemtob D, Pessach N, Nitzan-Kaluski D. Human immunodeficiency virus in newborn of infected mothers: Pregnancy, breast feeding and prevention. Harefuah [Internet]. 2006;145(9):682–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845401153&partnerID=40&md5=afa91f3dbaefc343dd0f26f166a0354a

68.

Chemtob D, Damelin B, Bessudo-Manor N, Hassman R, Amikam Y, Zenilman JM, et al. “Getting AIDS: Not in my back yard.” Results from a national knowledge, attitudes and practices survey. Israel Medical Association Journal [Internet]. 2006;8(9):610–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749042794&partnerID=40&md5=3a080b43fe60f51b1650276102713321

69.

Chemtob D, Weiler-Ravell D, Leventhal A, Bibi H. Epidemiologic characteristics of pediatric active tuberculosis among immigrants from high to low tuberculosis-endemic countries: The Israeli experience. Israel Medical Association Journal [Internet]. 2006;8(1):21–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-30944438095&partnerID=40&md5=9dbbe0d9d65e915031caf6a2640d86cc

70.

Chemtob D, Srour SF. Epidemiology of HIV infection among Israeli Arabs. Public Health [Internet]. 2005;119(2):138–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-13444272219&doi=10.1016%252fj.puhe.2004.02.011&partnerID=40&md5=d2fc4fd381d94395145c4d0d4db10dce

71.

Chemtob D, Grossman Z. Epidemiology of adult and adolescent HIV infection in Israel: A country of immigration. International Journal of STD and AIDS [Internet]. 2004;15(10):691–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4944241408&doi=10.1258%252f0956462041944321&partnerID=40&md5=50670575442f4a3976fa7ae6c1602ec5

72.

Weiler-Ravell D, Leventhal A, Berlowitz Y, Rishpon S, Chemtob D. Circumstances leading to the formulation and implementation of a new TB control program in Israel: A case study in public health and policy. Journal of Public Health Policy [Internet]. 2004;25(1):23–37. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1842423679&doi=10.1057%252fpalgrave.jphp.3190002&partnerID=40&md5=818f14862b8b96a0649d4d3493d746ab

73.

Weiler-Ravell D, Leventhal A, Coker RJ, Chemtob D. Compulsory detention of recalcitrant tuberculosis patients in the context of a new uberculosis control programme in Israel. Public Health [Internet]. 2004;118(5):323–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2642526890&doi=10.1016%252fj.puhe.2003.10.005&partnerID=40&md5=4ea7ddae9e8f80a973501edf31c38c9e

74.

Chemtob D, Leventhal A, Weiler-Ravell D. Screening and management of tuberculosis in immigrants: The challenge beyond professional competence. International Journal of Tuberculosis and Lung Disease [Internet]. 2003;7(10):959–66. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141530559&partnerID=40&md5=6652628a85a7fddba62f1322ccae2635

75.

Chemtob D, Leventhal A, Berlowitz Y, Weiler-Ravell D. The new National Tuberculosis Control Programme in Israel, a country of high immigration. International Journal of Tuberculosis and Lung Disease [Internet]. 2003;7(9):828–36. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141682723&partnerID=40&md5=a997cd30f2e949276a4fcc807561628c

76.

Leventhal A, Berlowitz Y, Chemtob D. Migrant workers: Evolution of the Israel health system approach to the new social issue. Harefuah [Internet]. 2003;142(8–9):632-635+644. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141459320&partnerID=40&md5=93e8902e197f177bf7b7d8778bc7b496

77.

Chemtob D, Nitzan Kaluski D. Political commitment and public health prioritization. Israel Medical Association Journal [Internet]. 2002;4(3):234. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036285199&partnerID=40&md5=4b42e28637a91c5b1f5b7292a52cd02b

78.

Bibi H, Weiler-Ravell D, Shoseyov D, Feigin I, Arbelli Y, Chemtob D. Compliance to treatment of latent tuberculosis infection in a region of Israel. Israel Medical Association Journal [Internet]. 2002;4(1):13–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036185366&partnerID=40&md5=f4e0c4113edc6e23b29e648fec1b5fb1

79.

Chemtob D, Leventhal A, Weiler-Ravell D. Tuberculosis in Israel–main epidemiological aspects. Harefuah [Internet]. 2002;141(3):226–32, 316. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036512816&partnerID=40&md5=f54341b60b646cd1bdc83526c7006ea8

80.

Chemtob D, Leventhal A, Berlowitz Y, Weiler-Ravell D. The new national program for tuberculosis elimination in Israel. Harefuah [Internet]. 2002;141(3):265–71, 314. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036511965&partnerID=40&md5=22f46796554e0165407e1a6d479456f6

81.

Grossman Z, Vardinon N, Chemtob D, Alkan ML, Bentwich Z, Burke M, et al. Erratum: Genotypic variation of HIV-1 reverse transcriptase and protease: Comparative analysis of clade C and clade B (AIDS (2001) 15 (1453-1460)). [1]. AIDS [Internet]. 2001;15(16):2209. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035834465&doi=10.1097%252f00002030-200111090-00026&partnerID=40&md5=b9be30c313391d5101420d211af2c6af

82.

Chemtob D, Epstein L, Slater PE, Weiler-Ravell D. Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel. Israel Medical Association Journal [Internet]. 2001;3(7):479–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034837045&partnerID=40&md5=0028375a680dea9ae7abfa2f6565929a

83.

Grossman Z, Vardinon N, Chemtob D, Alkan ML, Bentwich Z, Burke M, et al. Genotypic variation of HIV-1 reverse transcriptase and protease: Comparative analysis of clade C and clade B. AIDS [Internet]. 2001;15(12):1453–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035902902&doi=10.1097%252f00002030-200108170-00001&partnerID=40&md5=1b03b37e5c53ea42596596588f71ce49

84.

Ravins M, Bercovier H, Chemtob D, Fishman Y, Rahav G. Molecular epidemiology of Mycobacterium tuberculosis infection in Israel. Journal of Clinical Microbiology [Internet]. 2001;39(3):1175–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035097597&doi=10.1128%252fJCM.39.3.1175-1177.2001&partnerID=40&md5=9d3b5aebafdadbfb7a78d4b2e0ae9731

85.

Chemtob D, Weiler-Ravell D, Ben-Dov I. Incorrect estimation of TB drug resistance in Israel, probably due to recruitment and collection biases [2] (multiple letters). International Journal of Tuberculosis and Lung Disease [Internet]. 2000;4(10):990–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033772615&partnerID=40&md5=a5e48dd1b584c45737544d6afc759387

86.

Srour-Fihmi S, Weiler-Ravell D, Kitzes R, Chemtob D. Routine two-step skin testing for tuberculosis in the staff of a geriatric hospital in Israel: Booster and conversion rates. Journal of Hospital Infection [Internet]. 2000;46(2):141–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033754030&doi=10.1053%252fjhin.2000.0787&partnerID=40&md5=b3224ee76f6c35334ee06164dfe9c34b

87.

Senba M, Chemtob D, Slater PE, Fassberg J, Larouze B. Prevention of chronic carriage of hepatitis B virus infection in Ethiopian immigrants [2]. Israel Journal of Medical Sciences [Internet]. 1992;28(5):308–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026750431&partnerID=40&md5=de4908810fe10170d6114abb319b6031

88.

Chemtob D, Fassberg J, Kalka I, Harlap S, Slater PE, Ever-Hadani P, et al. Prevention strategy of hepatitis B virus infection among the Ethiopian Community in Israel. Israel Journal of Medical Sciences [Internet]. 1991;27(5):273–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025885386&partnerID=40&md5=c9aeb7e460eecc5926300f8b082b6599

89.

Chemtob D, Kalka I, Fassberg Y. Research note: Blood drawing and hepatitis B ‐‐ the case of Ethiopian Jews in Israel. Sociology of Health & Illness [Internet]. 1990;12(2):216–26. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995002667&doi=10.1111%252f1467-9566.ep11376647&partnerID=40&md5=b84a848d89c51b30a0ffcfafb32cb5ee